New Study Exposes Grave Risks of Abortion Pills
Submitted by MAGA
Posted 4 hours ago
**Shocking New Study Unveils Dangers of Abortion Pills, Challenging Pro-Choice Narrative**
A new study has brought to light alarming statistics about the abortion pill, revealing that women who take mifepristone face a 22 times higher risk of life-threatening complications than previously reported.
Conducted by leading researchers at the Ethics and Public Policy Center, the study analyzed insurance claims from a wide range of programs, including Medicaid and Medicare, covering nearly 700,000 women over a six-year period.
This extensive analysis indicates that 10.9% of those who had chemical abortions with mifepristone experienced severe complications, including emergency room visits, hemorrhaging, and infections, which starkly contradicts the narrative presented by abortion advocates regarding the safety of these pills.
The FDA and the drug’s manufacturer, Danco Laboratories, have come under fire as the data reveal a significant disconnect between reported risks and actual outcomes, raising critical questions about the long-term effects of the abortion pill on women's health.
Ryan Anderson, President of the Ethics and Public Policy Center, described the findings as a "category 5 hurricane," shaking the foundations of the abortion industry's claims of safety and efficacy.
Despite ongoing efforts from pro-life advocates and medical professionals to persuade the FDA to reconsider the approval of mifepristone due to its dangerous side effects, the federal agency has maintained a regulatory environment that seems more concerned with expanding access than with women’s health outcomes.
Under the Biden administration, regulations have loosened considerably, allowing for telehealth consultations and mail-order prescriptions, which many argue further endanger women's lives due to inadequate oversight and lack of necessary medical evaluations.
As the debate around abortion continues to intensify, this groundbreaking study could potentially reshape public policy discussions, presenting a vital opportunity for pro-life advocates to emphasize the serious risks faced by women during chemical abortions.
With calls for the reinstatement of safety protocols that mandate in-person check-ups and physician-only prescriptions, the findings underscore a crucial message: women deserve better than a system that prioritizes political agendas over their health and safety.
As the nation grapples with the realities of abortion and its implications, this research serves as an urgent reminder that the well-being of women must remain at the forefront of all discussions surrounding reproductive health.
Sources:
clashdaily.com
thepeoplesvoice.tv
rumble.com
A new study has brought to light alarming statistics about the abortion pill, revealing that women who take mifepristone face a 22 times higher risk of life-threatening complications than previously reported.
Conducted by leading researchers at the Ethics and Public Policy Center, the study analyzed insurance claims from a wide range of programs, including Medicaid and Medicare, covering nearly 700,000 women over a six-year period.
This extensive analysis indicates that 10.9% of those who had chemical abortions with mifepristone experienced severe complications, including emergency room visits, hemorrhaging, and infections, which starkly contradicts the narrative presented by abortion advocates regarding the safety of these pills.
The FDA and the drug’s manufacturer, Danco Laboratories, have come under fire as the data reveal a significant disconnect between reported risks and actual outcomes, raising critical questions about the long-term effects of the abortion pill on women's health.
Ryan Anderson, President of the Ethics and Public Policy Center, described the findings as a "category 5 hurricane," shaking the foundations of the abortion industry's claims of safety and efficacy.
Despite ongoing efforts from pro-life advocates and medical professionals to persuade the FDA to reconsider the approval of mifepristone due to its dangerous side effects, the federal agency has maintained a regulatory environment that seems more concerned with expanding access than with women’s health outcomes.
Under the Biden administration, regulations have loosened considerably, allowing for telehealth consultations and mail-order prescriptions, which many argue further endanger women's lives due to inadequate oversight and lack of necessary medical evaluations.
As the debate around abortion continues to intensify, this groundbreaking study could potentially reshape public policy discussions, presenting a vital opportunity for pro-life advocates to emphasize the serious risks faced by women during chemical abortions.
With calls for the reinstatement of safety protocols that mandate in-person check-ups and physician-only prescriptions, the findings underscore a crucial message: women deserve better than a system that prioritizes political agendas over their health and safety.
As the nation grapples with the realities of abortion and its implications, this research serves as an urgent reminder that the well-being of women must remain at the forefront of all discussions surrounding reproductive health.
Sources:
clashdaily.com
thepeoplesvoice.tv
rumble.com
Latest News